Miconazole%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520vaginal%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520pessary

## Miconazole Vaginal Pessary ### Overview Miconazole is an imidazole antifungal agent used to treat vulvovaginal candidiasis. The vaginal pessary formulation is a solid dosage form inserted into the vagina. ### Primary Indications Treatment of vaginal yeast infections (vulvovaginal candidiasis) caused by *Candida* species. ### Adult Dosing A single vaginal pessary (typically 100 mg) is inserted into the vagina. Some products may contain 200 mg per pessary and are also used as a single dose. Refer to specific product labeling. ### Pediatric Dosing No specific pediatric dosing recommendations are established for the vaginal pessary formulation. Use in pediatric patients is generally not recommended without specific guidance. ### Dose Adjustments No dose adjustments are necessary based on renal or hepatic impairment for the vaginal pessary formulation due to minimal systemic absorption. ### Contraindications Hypersensitivity to miconazole or any component of the formulation. ### Adverse Effects Common: Vaginal burning, itching, irritation, pelvic cramps. Less Common: Headache, rash. ### Key Drug Interactions * **CYP3A4 Inhibitors:** Miconazole can inhibit CYP3A4, increasing the concentration of substrates metabolized by this enzyme (e.g., warfarin, certain statins, some immunosuppressants). Although systemic absorption of vaginal miconazole is minimal, caution is advised, especially with prolonged use or in patients using interacting medications. * **Tacrolimus:** Concomitant use may increase tacrolimus levels. ### Monitoring * Monitor for relief of symptoms. * Assess for signs of local irritation or allergic reaction. * For patients on systemic interacting medications (e.g., warfarin), monitor for signs of toxicity. ### Clinical Pearls * The vaginal pessary should be inserted as deeply as possible into the vagina, preferably at bedtime to minimize leakage. * Treatment duration is typically a single dose, but may extend to 3 days depending on the product formulation and severity of infection. * Avoid sexual intercourse during treatment. * Advise patients that symptoms may not improve immediately. If symptoms persist after completing treatment, re-evaluation is recommended. *** *This information is intended for healthcare professionals. Always verify current prescribing information and consult with a qualified healthcare provider before making any treatment decisions.*